Quick Takeaways
- Invus Global Management, LLC filed SCHEDULE 13G for DBV Technologies S.A. Ordinary Shares, nominal value Euro 0.10 per share (DBVT).
- Disclosed ownership: 7.8%.
- Date of event: 06 Oct 2025.
Quoteable Key Fact
"Invus Global Management, LLC disclosed 7.8% ownership in DBV Technologies S.A. Ordinary Shares, nominal value Euro 0.10 per share (DBVT) on 06 Oct 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Invus Public Equities, L.P. | 7% | 10,438,485 | 10,438,485 | 0 | /s/ Raymond Debbane | Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner | |
| Invus Public Equities Advisors, LLC | 7% | 10,438,485 | 10,438,485 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Invus Global Management, LLC | 7% | 10,438,485 | 10,438,485 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Siren, L.L.C. | 7% | 10,438,485 | 10,438,485 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Avicenna Life Sci Master Fund LP | 0.7% | 1,099,975 | 1,099,975 | 0 | /s/ Raymond Debbane | Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner | |
| Avicenna Life Sci Master GP LLC | 0.7% | 1,099,975 | 1,099,975 | 0 | /s/ Raymond Debbane | Raymond Debbane, Chief Executive Officer | |
| Ulys, L.L.C. | 0.7% | 1,099,975 | 1,099,975 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Raymond Debbane | 7.8% | 11,538,460 | 11,538,460 | 0 | /s/ Raymond Debbane | Raymond Debbane |